- Home
- BMR vs BNR Comparison
BMR vs BNR Comparison
Compare BMR & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- BNR
- Stock Information
- Founded
- BMR 2009
- BNR 2014
- Country
- BMR Israel
- BNR China
- Employees
- BMR N/A
- BNR N/A
- Industry
- BMR Computer Software: Prepackaged Software
- BNR Medical Specialities
- Sector
- BMR Technology
- BNR Health Care
- Exchange
- BMR Nasdaq
- BNR Nasdaq
- Market Cap
- BMR 47.4M
- BNR 38.3M
- IPO Year
- BMR 2023
- BNR 2020
- Fundamental
- Price
- BMR $2.15
- BNR $12.25
- Analyst Decision
- BMR
- BNR
- Analyst Count
- BMR 0
- BNR 0
- Target Price
- BMR N/A
- BNR N/A
- AVG Volume (30 Days)
- BMR 238.9K
- BNR 33.9K
- Earning Date
- BMR 08-13-2025
- BNR 12-02-2025
- Dividend Yield
- BMR N/A
- BNR N/A
- EPS Growth
- BMR N/A
- BNR N/A
- EPS
- BMR N/A
- BNR N/A
- Revenue
- BMR $3,131,000.00
- BNR $74,862,782.00
- Revenue This Year
- BMR $21.21
- BNR $136.32
- Revenue Next Year
- BMR N/A
- BNR N/A
- P/E Ratio
- BMR N/A
- BNR N/A
- Revenue Growth
- BMR 5.96
- BNR 5.20
- 52 Week Low
- BMR $1.86
- BNR $2.18
- 52 Week High
- BMR $6.59
- BNR $13.89
- Technical
- Relative Strength Index (RSI)
- BMR 30.65
- BNR 60.87
- Support Level
- BMR $2.26
- BNR $11.31
- Resistance Level
- BMR $2.90
- BNR $12.71
- Average True Range (ATR)
- BMR 0.16
- BNR 1.04
- MACD
- BMR -0.06
- BNR 0.09
- Stochastic Oscillator
- BMR 3.57
- BNR 72.11
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.